Involving a number of players well known and respected in the space and with various prominent partners, Alliance Pharmaceutical had been using perfluorochemical technology to develop medical imaging and therapeutic products. Three products that were brought to advanced stages of development were Imagent, an agent that enhances ultrasound images of blood flow abnormalities; Oxygent, a temporary oxygen carrier that reduces or eliminates the need for blood transfusions during elective surgery; and LiquiVent, a pulmonary drug used to treat patients with acute respiratory failure. The company was also developing alternative drug delivery systems using foams, gels, microemulsions, and other agents. Firm apears to have fallen victim to the 2008 recession beingunable to raise additional funds
